Rufaro Kashangura

Learn More
BACKGROUND The existing Bacillus Calmette–Guérin (BCG) vaccination provides partial protection against tuberculosis (TB). The modified vaccinia ankara virus-expressing antigen 85A (MVA85A) aims to boost BCG immunity. We evaluated the animal evidence supporting the testing of MVA85A in humans. METHODS Our protocol included in vivo preclinical studies of(More)
  • 1